Using fMRI to Differentiate Between Healthy Aging, Mild Cognitive Impairment, and Alzheimer's Patients
Author Information
Author(s): Oghabian Mohammad Ali, Batouli Seyed Amir Hossein, Norouzian Maryam, Ziaei Maryam, Sikaroodi Hajir
Primary Institution: Tehran University of Medical Sciences
Hypothesis
Can functional Magnetic Resonance Imaging (fMRI) effectively differentiate between Alzheimer’s disease, Mild Cognitive Impairment, and healthy aging?
Conclusion
fMRI can be used as a diagnostic criterion to differentiate between Alzheimer’s disease, Mild Cognitive Impairment, and healthy aging based on brain activation patterns.
Supporting Evidence
- Healthy aging subjects showed greater brain activation in the Posterior Cingulate Cortex compared to MCI and Alzheimer's groups.
- The study included a total of 40 subjects, with a final analysis of 29 after data omission.
- fMRI data were analyzed using Independent Component Analysis to identify brain activation patterns.
Takeaway
This study used brain scans to see how healthy older people, those with Mild Cognitive Impairment, and Alzheimer's patients think differently. It found that healthy brains work better in certain areas.
Methodology
The study compared resting-state brain activation patterns among three groups using fMRI and Independent Component Analysis (ICA).
Limitations
Some imaging data were omitted from the final analysis due to technical issues or patient inability to comply with resting-state conditions.
Participant Demographics
40 subjects: 15 healthy elderly (8 males, 7 females), 11 with Mild Cognitive Impairment (5 males, 6 females), and 14 Alzheimer's patients (8 males, 6 females).
Statistical Information
P-Value
0.0051 for healthy aging vs AD, 0.0097 for healthy aging vs MCI, 0.0168 for MCI vs AD
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website